Antoine Yver logo AstraZeneca logo

Antoine Yver

Senior Vice President, Head of Oncology Global Medicines Development, AstraZeneca LP (UK)


Antoine Yver leads our global oncology late stage development organisation in GMD, other than Immuno-Oncology, as well as the GMD organisation for China. He joined AstraZeneca in November 2009 after 19 years in the thick of oncology drug development, in France, the UK and since 1998 in and from the USA, working for Merck/Schering-Plough, Johnson & Johnson, Aventis and its predecessor Rhône-Poulenc Rorer.

Antoine has a track record of successfully leading the global clinical development of novel small and large molecules oncology medicines, such as Granocyte®, Sylatron®, Yondelis®, Caprelsa®, as well as successfully delivering major line extensions for Taxotere® and Doxil® and contributing to significant in-licensing business development deals.

Antoine, a paediatrician oncologist by training and practice, received his MSc and MD degrees from University of Paris, France and held a full time academic appointment as Chef de Clinique Assistant des Hôpitaux in Paris prior to joining industry in 1990.

Antoine Yver logo

Antoine Yver

Senior Vice President, Head of Oncology Global Medicines Development, AstraZeneca LP (UK)


AstraZeneca logo

Antoine Yver leads our global oncology late stage development organisation in GMD, other than Immuno-Oncology, as well as the GMD organisation for China. He joined AstraZeneca in November 2009 after 19 years in the thick of oncology drug development, in France, the UK and since 1998 in and from the USA, working for Merck/Schering-Plough, Johnson & Johnson, Aventis and its predecessor Rhône-Poulenc Rorer.

Antoine has a track record of successfully leading the global clinical development of novel small and large molecules oncology medicines, such as Granocyte®, Sylatron®, Yondelis®, Caprelsa®, as well as successfully delivering major line extensions for Taxotere® and Doxil® and contributing to significant in-licensing business development deals.

Antoine, a paediatrician oncologist by training and practice, received his MSc and MD degrees from University of Paris, France and held a full time academic appointment as Chef de Clinique Assistant des Hôpitaux in Paris prior to joining industry in 1990.


Why WIN